Valar Labs alternatives and competitors
The closest alternatives to Valar Labs are ArteraAI, DoMore Diagnostics, Nucleai and Veracyte.
Valar Labs is a precision oncology company, founded in 2021, whose tests predict treatment response and prognosis from routine H and E slides using its Computational Histology AI platform, trained on more than 500,000 pathologist annotations.
10 alternatives to Valar Labs
What each product does, with its price as the vendor publishes it.
-
A
ArteraAI is the Los Altos, California company at artera.ai that builds multimodal AI cancer tests. It is unrelated to Artera of Santa Barbara (artera.io), which makes patient communication agents.
-
D
Histotype Px Colorectal predicts recurrence and survival in stage II and III colorectal cancer from standard H and E stained slides, placing patients in low, intermediate or high risk groups to inform whether adjuvant chemotherapy should follow surgery.
Price: No published price
-
N
Tissue intelligence company for drug development, applying computer vision and machine learning to H&E, immunohistochemistry, multiplex imaging and spatial transcriptomics and linking tissue features to clinical outcomes.
Price: No published price
-
V
Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Price: No published price
-
L
Lumea's argument is that digital pathology fails upstream of the software, at the specimen, so its products start at the biopsy.
-
C
Caris Life Sciences (NASDAQ: CAI) is a precision oncology company in Irving, Texas. It profiles tumors in its own laboratories by whole exome and whole transcriptome sequencing and layers AI signatures on the results.
Price: No published price
-
P
PreciseDx sells PreciseBreast, a test that predicts whether early breast cancer will come back, using AI to read the cell patterns on a routine stained slide.
Price: No published price
-
P
Paige sells AI applications that help pathologists find and classify cancer on digitized slides, for prostate, breast, gastrointestinal and pan cancer pathology, along with a pathologist co-pilot called Alba, the FullFocus viewer and a family of foundation models (Virchow, Virchow2…
-
B
bioAffinity Technologies (NASDAQ: BIAF) develops noninvasive tests for lung disease, led by CyPath Lung, a laboratory developed test that pulmonologists and other physicians order for high risk patients with indeterminate pulmonary nodules.
Price: No published price
-
M
MyOme is a genomics company in Menlo Park, California, with a CLIA certified and CAP accredited laboratory, that sells whole genome screening built around integrated risk scores.
Price: No published price
Valar Labs alternatives, answered
What are the best alternatives to Valar Labs?
The closest alternatives to Valar Labs are ArteraAI, DoMore Diagnostics, Nucleai, Veracyte and Lumea. ArteraAI is the Los Altos, California company at artera.ai that builds multimodal AI cancer tests. Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery. Lumea's argument is that digital pathology fails upstream of the software, at the specimen, so its products start at the biopsy.
Who are Valar Labs's competitors?
Valar Labs's competitors in the Digital Pathology AI category include ArteraAI, DoMore Diagnostics, Nucleai, Lumea, PreciseDx and Paige.